Douglas J. Swirsky
Overview
Douglas J. Swirsky received an average of $1M in total compensation, including $376K in salary, at Rexahn Pharmaceuticals from 2018 to 2020.
Source: SEC filings on April 26, 2021 and April 29, 2019.
Related executives
We found ten more executives who work or worked at Rexahn Pharmaceuticals.
Mina Sooch
Rexahn Pharmaceuticals
Chief Executive Officer
Amy Rabourn
Rexahn Pharmaceuticals
Vice President of Finance
Bernhard Hoffmann
Rexahn Pharmaceuticals
Vice President of Corporate Development and Operations
Peter Suzdak
Rexahn Pharmaceuticals
Chief Executive Officer
Ely Benaim
Rexahn Pharmaceuticals
Chief Medical Officer
Lisa Nolan
Rexahn Pharmaceuticals
Secretary
Tae Jeong
Rexahn Pharmaceuticals
Chief Financial Officer
Rakesh Soni
Rexahn Pharmaceuticals